ACE Inhibitors vs. ARBs for Patients with Diabetic Kidney Disease - Cochrane for ...
Jul 1, 2007 - Studies comparing ACE inhibitors or ARBs with placebo found no mortality benefit in patients with diabetic kidney disease. A subgroup analysis of five studies (2,034 total patients) found that, when given at full or maximally tolerated doses, ACE inhibitors reduce all-cause mortality ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2007/0701/p68.html
Angiotensin Blockade in Patients with Diabetic Nephropathy - FPIN's Clinical Inquiries ...
Aug 1, 2007 - When used to delay the progression of early nephropathy in patients with type 2 diabetes mellitus, angiotensin receptor blockers (ARBs) are not superior to angiotensin-converting enzyme (ACE) inhibitors.
American Family Physician : FPIN's Clinical Inquiries
https://www.aafp.org/afp/2007/0801/p423.html
Diabetic Nephropathy - Clinical Evidence Handbook - American Family Physician
Dec 1, 2005 - What are the effects of treatments in persons with type 1 diabetes and early or late nephropathy? What are the effects of treatments in persons with type 2 diabetes and early or late nephropathy?
American Family Physician : Clinical Evidence Handbook
https://www.aafp.org/afp/2005/1201/p2299.html
Diabetic Nephropathy: Preventing Progression - Clinical Evidence Handbook - American ...
Mar 15, 2011 - What are the effects of treatments to prevent progression of nephropathy in persons with type 1 and type 2 diabetes and early and late nephropathy?
American Family Physician : Clinical Evidence Handbook
https://www.aafp.org/afp/2011/0315/p732.html
Page 1